Industries
Every US-listed company grouped by sector and industry. Drill from sectors into industry groups and individual industries to compare returns, breadth and momentum.
Close 2026-10-14 · S&P 500 1D −1.08%
Companies
223
Market cap
$4.82T
1D cap-weighted
+2.51%
1D median stock
−0.32%
1D vs S&P
+3.59%
Above 200-day
37%
52-wk highs / lows
3 / 22
Median RSI
36
LLY+3.6%JNJ+2.1%ABBV+3.3%MRK+3.8%NVS+3.1%AZN+4.0%ABT+0.3%NVO+0.2%PFE+3.0%VRTX+2.7%BMY+4.6%SNY+1.7%GSK+3.5%REGN+3.4%TAK+2.6%TEVA−1.3%ONC+0.7%ZTS+1.3%ALNY+0.3%RPRX+4.3%ROIV+0.8%UTHR−0.6%GMAB+0.9%INSM+1.0%VTRS+1.1%ASND+1.7%JAZZ−0.3%CORT−1.3%SMMT−2.5%BBIO+2.6%ELAN+0.6%RDY−0.2%BMRN+1.4%MDGL+1.8%PTGX−1.6%CYTK+2.9%TGTX+0.1%ARWR+0.4%AXSM+3.8%ABVX+2.0%SYRE−2.3%IONS+0.8%AMRX−3.4%PRAX−1.8%ALKS−1.6%KNSA+0.4%BLTE+0.6%LGND−2.8%RYTM+0.1%ORKA−1.9%MIRM+0.4%ERAS−0.5%PTCT−0.4%TVTX+2.8%GRFS+1.0%COGT+0.2%MANE−2.4%DNTH−3.6%INDV−3.6%ABCL−1.9%EWTX+2.0%TNGX−0.1%TLX−2.5%OGN−0.2%LEGN+6.5%VKTX−4.4%AMLX+0.7%XENE−1.5%PBLS−3.6%IDYA−1.2%ARQT+1.2%ACAD+3.4%ELVN−0.5%RCUS+0.1%DYN−1.7%PGEN−1.7%ZLAB−2.6%SLS−4.3%SUPN−4.4%NRIX+7.0%NAMS−0.9%LQDA+26.6%MBX−0.4%HCM−0.1%PBH−0.2%BHC0.0%AUPH+1.5%IRON−1.5%HRMY+1.3%PRGO+3.8%PHVS0.0%IMNM−2.2%VRDN+0.9%SDGR−3.2%VERA−0.2%LKFT+1.2%ADRX+0.7%URGN−4.4%XERS−4.2%MLYS−1.1%PVLA−4.6%AGIO+2.5%ZYME−1.2%TRVI−1.9%XNCR−0.6%SRPT+1.9%BHVN−4.3%SEPN−0.3%NUVB−0.8%ZBIO−1.2%ANIP−1.0%GPCR−1.9%OCUL−0.6%GENB+2.2%CMPS+1.2%ETON−0.8%INVA+1.1%PAHC+3.0%QURE−1.5%RARE−0.1%STOK+3.4%PCRX+0.3%KRSA+8.4%AAPG−1.4%KLRA−0.3%RAPP−2.3%OMER−2.4%ANAB+2.4%NKTR−2.7%GHRS−1.5%TYRA+0.8%SNDX−3.0%KARD+4.2%ORIC+2.5%BCAX0.0%DMRA−0.7%TRAX+7.7%LBRX−2.3%AMPH+0.1%NBTX−1.0%HROW−3.5%AVLN−0.2%JANX−0.3%OPK+3.8%SVRA−0.4%MNKD−1.0%MRVI+0.3%AKTS−0.9%MLTX−2.6%RIGL−0.7%KURA−2.2%ANRO−1.7%SPTX+3.7%CYRX−1.8%JBIO+0.1%ALMS−7.6%ABUS+1.9%ARDX+2.2%AVBP+0.7%CRVS−0.3%GERN−0.8%HELP−1.1%ANL−7.4%APMD−3.4%OBX+1.9%ANNX−4.2%IMMX−2.1%LXRX−0.6%GYRE−3.6%COLL+4.5%IVA0.0%VSTM+3.5%PHAR+2.1%AVTX−1.4%WVE−1.6%ZVRA−1.5%OLMA−3.1%DSGN−0.5%IRWD+0.3%NVCT−0.8%CLYM−0.2%AQST−1.3%CRMD0.0%PHAT+5.7%SGMT−5.5%FTH−7.0%SLN+1.2%STTK−2.9%PBYI+0.8%ACRS−2.6%DRUG−1.3%CTMX−4.1%EOLS−3.9%MNPR+1.4%CBIO−2.6%EVO+6.0%ALT−4.9%OCS−5.9%ARVN−0.3%RZLT−8.2%KMDA−1.2%EPRX−1.4%MPLT−0.8%NGNE+2.9%PRTA+0.1%OVID0.0%DMAC−2.0%PRE−3.1%ASMB+0.9%SPRY−3.0%CAPR−4.2%AVIR−7.0%GALT−1.4%RLMD−3.6%EBS0.0%IRD−3.3%ARCT−7.6%ENTA−3.0%TTRX+4.8%INDP−7.5%CTNM−3.3%CYPH−7.8%BNTC−3.9%
Tiles are sized by market cap and coloured by return over the chosen period. Click a group or tile to drill in; click a company for its quote. Search for a company to see where it sits.
Companies in Pharmaceutical Preparations
223| Symbol | Name | Market cap | 1D | 1M | YTD | 1Y | RSI | > 50-day | > 200-day | 52-wk |
|---|---|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co. | $1.04T | +3.62% | +6.39% | +12.47% | +47.52% | 60 | ✓ | ✓ | |
| JNJ | Johnson & Johnson | $599B | +2.13% | −4.97% | +22.69% | +33.01% | 41 | ✓ | ||
| ABBV | Abbvie Inc. | $485B | +3.32% | +7.77% | +24.07% | +23.09% | 70 | ✓ | ✓ | High |
| MRK | Merck & Co., Inc. | $350B | +3.80% | +2.49% | +40.01% | +71.96% | 55 | ✓ | ✓ | |
| NVS | Novartis AG | $271B | +3.14% | +5.96% | +6.54% | +13.75% | 56 | |||
| AZN | AstraZeneca PLC | $242B | +3.99% | +0.11% | +76.25% | +91.73% | 51 | ✓ | ||
| ABT | Abbott Laboratories | $178B | +0.35% | +0.92% | −17.81% | −21.62% | 54 | |||
| NVO | Novo-Nordisk A/S | $168B | +0.16% | −10.37% | −25.08% | −33.70% | 36 | |||
| PFE | Pfizer Inc. | $162B | +2.96% | +6.03% | +17.31% | +18.12% | 66 | ✓ | ✓ | High |
| VRTX | Vertex Pharmaceuticals Inc | $123B | +2.74% | −3.13% | +9.96% | +22.37% | 42 | ✓ | ||
| BMY | Bristol-Myers Squibb Co. | $116B | +4.61% | −6.98% | +9.90% | +36.15% | 42 | |||
| SNY | Sanofi | $93.7B | +1.66% | −6.20% | −17.93% | −18.50% | 37 | |||
| GSK | GSK plc | $92.7B | +3.46% | −4.28% | −2.39% | +9.57% | 47 | |||
| REGN | Regeneron Pharmaceuticals Inc | $77.5B | +3.35% | +0.55% | +0.84% | +39.56% | 54 | ✓ | ||
| TAK | Takeda Pharmaceutical Company Limited | $59.2B | +2.65% | +1.66% | +21.94% | +38.56% | 61 | ✓ | ✓ | |
| TEVA | Teva Pharmaceutical Industries Limited | $48.1B | −1.28% | +3.75% | +30.47% | +103.40% | 61 | ✓ | ✓ | |
| ONC | BeOne Medicines Ltd. | $39.5B | +0.69% | +1.44% | +15.69% | +7.48% | 46 | ✓ | ||
| ZTS | Zoetis Inc. | $30.7B | +1.33% | +2.53% | −40.16% | −47.08% | 59 | ✓ | ||
| ALNY | Alnylam Pharmaceuticals, Inc. | $29.9B | +0.29% | −5.79% | −43.55% | −51.72% | 40 | |||
| RPRX | Royalty Pharma plc | $25.2B | +4.28% | +0.89% | +52.67% | +66.45% | 55 | ✓ | ||
| ROIV | Roivant Sciences Ltd. | $24.1B | +0.81% | −14.89% | +54.93% | +107.40% | 37 | ✓ | ||
| UTHR | United Therapeutics Corp | $23.3B | −0.62% | +7.93% | +10.83% | +22.72% | 56 | ✓ | ✓ | |
| GMAB | Genmab A/S | $22.5B | +0.88% | +8.02% | +19.77% | +12.88% | 59 | ✓ | ✓ | |
| INSM | Insmed, Inc. | $21.1B | +1.03% | −18.45% | −43.81% | −40.35% | 29 | |||
| VTRS | Viatris Inc. | $19.8B | +1.10% | +4.74% | +40.08% | +76.88% | 53 | ✓ | ✓ | |
| ASND | Ascendis Pharma A/S Ordinary Share | $14.7B | +1.70% | −5.33% | +6.45% | +8.91% | 43 | |||
| JAZZ | Jazz Pharmaceuticals, Inc. | $13.7B | −0.35% | −12.95% | +23.32% | +55.14% | 22 | |||
| CORT | Corcept Therapeutics Inc. | $12.7B | −1.33% | +4.88% | +233.99% | +62.49% | 50 | ✓ | ✓ | |
| SMMT | Summit Therapeutics Inc. | $12.4B | −2.51% | −13.05% | −13.49% | −34.02% | 41 | |||
| BBIO | BridgeBio Pharma, Inc. | $12.4B | +2.59% | −5.04% | −15.10% | +16.05% | 38 | |||
| ELAN | Elanco Animal Health Incorporated | $11.2B | +0.62% | −1.96% | −0.35% | +12.52% | 47 | |||
| RDY | Dr. Reddy's Laboratories Limited | $10.6B | −0.16% | +10.39% | −9.19% | −11.21% | 59 | ✓ | ||
| BMRN | BioMarin Pharmaceuticals Inc | $10.5B | +1.40% | −14.45% | −7.22% | +5.13% | 30 | |||
| MDGL | Madrigal Pharmaceuticals, Inc. | $10.4B | +1.75% | −12.09% | −21.01% | +7.55% | 28 | |||
| PTGX | Protagonist Therapeutics, Inc | $8.96B | −1.60% | −4.97% | +56.03% | +72.14% | 40 | ✓ | ||
| CYTK | Cytokinetics Inc. | $8.57B | +2.94% | −8.48% | −0.17% | +6.44% | 39 | |||
| TGTX | TG Therapeutics, Inc. | $8.32B | +0.06% | +2.51% | +82.39% | +58.88% | 49 | ✓ | ✓ | |
| ARWR | Arrowhead Research Corporation | $8.21B | +0.41% | −17.40% | −12.08% | +61.02% | 27 | |||
| AXSM | Axsome Therapeutics, Inc | $8.19B | +3.77% | −20.51% | −11.18% | +33.90% | 27 | |||
| ABVX | Abivax SA | $7.52B | +2.04% | −17.51% | −34.76% | −8.00% | 34 | |||
| SYRE | Spyre Therapeutics, Inc. | $7.52B | −2.26% | −13.55% | +140.02% | +315.70% | 37 | ✓ | ||
| IONS | Ionis Pharmaceuticals, Inc. | $7.04B | +0.76% | −9.63% | −46.02% | −39.51% | 35 | Low | ||
| AMRX | Amneal Pharmaceuticals, Inc. | $6.82B | −3.42% | +13.51% | +50.00% | +93.85% | 46 | ✓ | ✓ | |
| PRAX | Praxis Precision Medicines, Inc. | $6.79B | −1.78% | −23.61% | −18.90% | +356.67% | 22 | |||
| ALKS | Alkermes Inc. plc | $6.67B | −1.64% | −15.10% | +39.67% | +21.48% | 31 | |||
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.13B | +0.39% | +4.91% | +91.13% | +112.91% | 57 | ✓ | ✓ | |
| BLTE | Belite Bio, Inc | $6.12B | +0.56% | −9.87% | −4.53% | +91.45% | 39 | |||
| LGND | Ligand Pharmaceuticals Inc. | $6.05B | −2.81% | +6.50% | +56.02% | +63.98% | 48 | ✓ | ✓ | |
| RYTM | Rhythm Pharmaceuticals, Inc. | $5.96B | +0.12% | −10.40% | −18.99% | −13.95% | 26 | |||
| ORKA | Oruka Therapeutics, Inc. | $5.18B | −1.93% | −16.83% | +152.99% | +200.65% | 33 | ✓ | ||
| MIRM | Mirum Pharmaceuticals, Inc. | $5.17B | +0.43% | −14.85% | +1.23% | +10.79% | 34 | |||
| ERAS | Erasca, Inc. | $5.17B | −0.54% | −9.54% | +295.16% | +512.50% | 45 | ✓ | ||
| PTCT | PTC Therapeutics, Inc. | $5.00B | −0.42% | −9.11% | −21.45% | −9.67% | 33 | Low | ||
| TVTX | Travere Therapeutics, Inc. | $4.88B | +2.84% | −14.78% | +39.41% | +103.32% | 34 | ✓ | ||
| GRFS | Grifois, S.A. | $4.88B | +0.98% | −1.63% | −22.57% | −23.39% | 41 | |||
| COGT | Cogent Biosciences, Inc. | $4.87B | +0.21% | −14.02% | −20.75% | +73.77% | 28 | |||
| MANE | Veradermics, Incorporated | $4.86B | −2.40% | +9.22% | — | — | 49 | ✓ | — | |
| DNTH | Dianthus Therapeutics, Inc. | $4.34B | −3.63% | −28.64% | +81.41% | +117.20% | 16 | |||
| INDV | Indivior Pharmaceuticals, Inc. | $4.18B | −3.56% | −0.18% | −4.79% | +43.11% | 38 | |||
| ABCL | AbCellera Biologics Inc. | $4.09B | −1.90% | +8.41% | +261.70% | +118.17% | 49 | ✓ | ✓ | |
| EWTX | Edgewise Therapeutics, Inc. | $3.94B | +2.04% | −15.15% | +49.18% | +151.67% | 34 | ✓ | ||
| TNGX | Tango Therapeutics, Inc. | $3.75B | −0.14% | −7.12% | +150.45% | +161.98% | 43 | ✓ | ||
| TLX | Telix Pharmaceuticals Limited | $3.71B | −2.47% | −16.99% | +42.19% | +11.64% | 43 | ✓ | ||
| OGN | Organon & Co. | $3.62B | −0.22% | +0.59% | +91.63% | +43.13% | 52 | ✓ | ✓ | |
| LEGN | Legend Biotech Corporation | $3.48B | +6.49% | +7.75% | −12.42% | −42.04% | 50 | |||
| VKTX | Viking Therapeutics, Inc | $3.39B | −4.43% | −14.96% | −27.60% | −24.89% | 34 | Low | ||
| AMLX | Amylyx Pharmaceuticals, Inc. | $3.37B | +0.67% | −18.46% | +123.76% | +91.43% | 38 | ✓ | ||
| XENE | Xenon Pharmaceuticals Inc | $3.33B | −1.51% | −39.77% | −24.36% | −15.23% | 20 | Low | ||
| PBLS | Parabilis Medicines, Inc. | $3.32B | −3.58% | −27.52% | — | — | 30 | — | ||
| IDYA | IDEAYA Biosciences, Inc. | $3.31B | −1.17% | −10.09% | −2.05% | +26.48% | 31 | |||
| ARQT | Arcutis Biotherapeutics, Inc. | $3.28B | +1.23% | +12.34% | −9.06% | +27.46% | 55 | ✓ | ✓ | |
| ACAD | Acadia Pharmaceuticals Inc. | $3.21B | +3.38% | −28.06% | −27.93% | −4.04% | 24 | |||
| ELVN | Enliven Therapeutics, Inc. | $2.89B | −0.53% | −26.39% | +155.06% | +89.94% | 21 | |||
| RCUS | Arcus Biosciences, Inc. | $2.87B | +0.09% | −7.36% | −5.46% | +35.40% | 32 | |||
| DYN | Dyne Therapeutics, Inc. | $2.86B | −1.70% | −15.98% | −23.11% | +7.20% | 29 | |||
| PGEN | Precigen, Inc. | $2.68B | −1.67% | +5.07% | +75.96% | +129.13% | 47 | ✓ | ✓ | |
| ZLAB | Zai Lab Limited | $2.59B | −2.60% | −9.27% | +27.55% | −27.95% | 35 | ✓ | ||
| SLS | SELLAS Life Sciences Group, Inc. | $2.51B | −4.27% | +5.23% | +215.12% | +494.00% | 49 | ✓ | ||
| SUPN | Supernus Pharmaceuticals, Inc. | $2.45B | −4.36% | −2.66% | −19.15% | −16.95% | 35 | Low | ||
| NRIX | Nurix Therapeutics, Inc. | $2.42B | +6.96% | −4.67% | +24.78% | +143.52% | 50 | ✓ | ||
| NAMS | NewAmsterdam Pharma Company N.V. | $2.41B | −0.89% | −5.43% | −42.96% | −46.14% | 30 | Low | ||
| LQDA | Liquidia Corporation | $2.40B | +26.59% | −48.36% | −1.59% | +42.79% | 35 | |||
| MBX | MBX Biosciences, Inc. | $2.36B | −0.37% | −20.07% | +54.79% | +236.69% | 29 | ✓ | ||
| HCM | HUTCHMED (China) Limited | $2.35B | −0.15% | −2.25% | +1.13% | −12.41% | 47 | ✓ | ✓ | |
| PBH | Prestige Consumer Healthcare Inc. | $2.30B | −0.21% | +3.68% | −21.54% | −21.73% | 54 | |||
| BHC | Bausch Health Companies Inc | $2.20B | 0.00% | +3.88% | −15.25% | −3.60% | 48 | ✓ | ||
| AUPH | Aurinia Pharmaceuticals Inc | $2.18B | +1.53% | +2.98% | +4.14% | +49.64% | 56 | ✓ | ✓ | |
| IRON | Disc Medicine, Inc. | $2.17B | −1.52% | −17.18% | −29.81% | −22.54% | 20 | |||
| HRMY | Harmony Biosciences Holdings, Inc. | $2.16B | +1.30% | −11.05% | +0.24% | +42.30% | 37 | ✓ | ||
| PRGO | Perrigo Company Plc | $2.13B | +3.77% | +17.63% | +14.58% | −24.73% | 66 | ✓ | ✓ | |
| PHVS | Pharvaris N.V. | $2.11B | 0.00% | −21.12% | +8.18% | +36.02% | 30 | |||
| IMNM | Immunome, Inc. | $2.07B | −2.16% | −28.18% | −19.93% | +20.70% | 23 | |||
| VRDN | Viridian Therapeutics, Inc. | $2.06B | +0.88% | −15.80% | −40.94% | −13.99% | 35 | |||
| SDGR | Schrodinger, Inc. | $1.94B | −3.24% | +7.74% | +40.10% | +27.16% | 45 | ✓ | ✓ | |
| VERA | Vera Therapeutics, Inc. | $1.93B | −0.19% | −20.58% | −47.20% | −12.30% | 29 | |||
| LKFT | Lakefront Biotherapeutics | $1.90B | +1.20% | +5.30% | — | — | 52 | ✓ | — | |
| ADRX | ADARx Pharmaceuticals, Inc. | $1.89B | +0.73% | — | — | — | — | — | — | |
| URGN | UroGen Pharma Ltd. | $1.87B | −4.39% | −12.36% | +56.19% | +118.26% | 33 | ✓ | ||
| XERS | Xeris Biopharma Holdings, Inc. | $1.86B | −4.22% | +30.44% | +24.46% | +22.89% | 56 | ✓ | ✓ | |
| MLYS | Mineralys Therapeutics, Inc. | $1.86B | −1.14% | −28.19% | −42.79% | −51.78% | 31 | |||
| PVLA | Palvella Therapeutics, Inc. | $1.85B | −4.61% | −18.94% | +17.11% | +60.82% | 32 | |||
| AGIO | Agios Pharmaceuticals, Inc. | $1.80B | +2.52% | −5.61% | +13.78% | −24.32% | 40 | |||
| ZYME | Zymeworks Inc. | $1.80B | −1.20% | −4.91% | −5.92% | +36.78% | 41 | |||
| TRVI | Trevi Therapeutics, Inc. | $1.75B | −1.87% | −19.81% | −3.67% | +24.20% | 20 | |||
| XNCR | Xencor, Inc. | $1.75B | −0.55% | −1.52% | +52.78% | +67.55% | 42 | ✓ | ||
| SRPT | Sarepta Therapeutics,, Inc. | $1.74B | +1.94% | −18.77% | −21.79% | −23.36% | 38 | |||
| BHVN | Biohaven Ltd. | $1.72B | −4.29% | −11.43% | −3.19% | −28.56% | 31 | |||
| SEPN | Septerna, Inc. | $1.70B | −0.26% | −6.54% | +30.27% | +50.77% | 43 | ✓ | ||
| NUVB | Nuvation Bio Inc. | $1.66B | −0.85% | −19.31% | −47.77% | +27.17% | 26 | |||
| ZBIO | Zenas BioPharma, Inc. | $1.64B | −1.19% | −22.14% | −31.53% | −6.33% | 35 | ✓ | ||
| ANIP | ANI Pharmaceuticals, Inc. | $1.63B | −0.96% | −2.70% | −11.12% | −20.82% | 39 | |||
| GPCR | Structure Therapeutics Inc. | $1.59B | −1.93% | −43.83% | −68.54% | −27.53% | 11 | Low | ||
| OCUL | Ocular Therapeutix, Inc. | $1.59B | −0.55% | −29.34% | −40.69% | −39.24% | 32 | |||
| GENB | Generate Biomedicines, Inc. | $1.57B | +2.16% | −22.67% | — | — | 34 | — | ||
| CMPS | COMPASS Pathways Plc | $1.54B | +1.17% | −18.39% | +63.33% | +79.17% | 35 | ✓ | ||
| ETON | Eton Pharmaceutcials, Inc. | $1.52B | −0.84% | −3.73% | +212.71% | +192.48% | 43 | ✓ | ||
| INVA | Innoviva, Inc. | $1.50B | +1.11% | +0.62% | +4.90% | +23.79% | 50 | ✓ | ||
| PAHC | Phibro Animal Health Corporation | $1.49B | +3.04% | +8.28% | +1.53% | +3.69% | 59 | ✓ | ||
| QURE | uniQure N.V. | $1.48B | −1.46% | −51.35% | −12.37% | −66.19% | 16 | |||
| RARE | Ultragenyx Pharmaceutical Inc. | $1.47B | −0.13% | +14.00% | −35.22% | −53.47% | 40 | |||
| STOK | Stoke Therapeutics, Inc. | $1.45B | +3.38% | −17.37% | −26.72% | −23.34% | 33 | |||
| PCRX | Pacira BioSciences, Inc. | $1.45B | +0.25% | +51.16% | +40.65% | +63.52% | 85 | ✓ | ✓ | High |
| KRSA | Korsana Biosciences, Inc. | $1.44B | +8.40% | +6.98% | — | — | 59 | — | — | |
| AAPG | Ascentage Pharma Group International | $1.41B | −1.39% | −7.19% | −43.41% | −59.26% | 44 | |||
| KLRA | Kailera Therapeutics, Inc. | $1.40B | −0.28% | −20.15% | — | — | 38 | — | ||
| RAPP | Rapport Therapeutics, Inc. | $1.39B | −2.28% | −33.62% | −6.62% | +8.17% | 21 | |||
| OMER | Omeros Corporation | $1.37B | −2.38% | +7.34% | +7.31% | +339.86% | 48 | ✓ | ✓ | |
| ANAB | AnaptysBio, Inc. | $1.36B | +2.37% | −14.65% | −3.73% | +43.78% | 33 | |||
| NKTR | Nektar Therapeutics | $1.29B | −2.72% | −44.64% | −12.75% | −35.73% | 20 | |||
| GHRS | GH Research PLC | $1.29B | −1.54% | −32.63% | +46.14% | +43.21% | 22 | |||
| TYRA | Tyra Biosciences, Inc. | $1.28B | +0.75% | −26.46% | −28.87% | +30.22% | 31 | |||
| SNDX | Syndax Pharmaceuticals, Inc. | $1.25B | −3.01% | −25.21% | −35.60% | −10.99% | 21 | |||
| KARD | Kardigan, Inc. | $1.21B | +4.24% | −27.16% | — | — | 36 | — | ||
| ORIC | Oric Pharmaceuticals, Inc. | $1.17B | +2.48% | −6.23% | +41.69% | −16.68% | 38 | ✓ | ||
| BCAX | Bicara Therapeutics Inc. | $1.15B | 0.00% | −23.51% | +3.03% | −6.32% | 31 | |||
| DMRA | Damora Therapeutics, Inc. | $1.15B | −0.70% | −25.54% | — | — | 30 | — | ||
| TRAX | First Tracks Biotherapeutics, Inc. | $1.13B | +7.73% | −11.28% | — | — | 46 | — | ||
| LBRX | LB Pharmaceuticals Inc | $1.12B | −2.27% | −21.00% | +52.74% | +111.57% | 33 | ✓ | ||
| AMPH | Amphastar Pharmaceuticals, Inc. | $1.11B | +0.12% | +10.32% | −2.61% | +10.93% | 59 | ✓ | ✓ | |
| NBTX | Nanobiotix S.A. | $1.09B | −0.98% | −39.65% | −7.96% | −29.79% | 22 | |||
| HROW | Harrow, Inc. | $1.06B | −3.54% | −19.50% | −44.41% | −29.74% | 18 | Low | ||
| AVLN | Avalyn Pharma Inc. | $1.05B | −0.21% | −30.89% | — | — | 27 | — | ||
| JANX | Janux Therapeutics, Inc. | $1.05B | −0.29% | +4.20% | +24.13% | −34.84% | 48 | ✓ | ||
| OPK | Opko Health Inc. | $985M | +3.79% | −12.74% | +8.73% | −9.27% | 36 | ✓ | ||
| SVRA | Savara Inc. | $982M | −0.42% | −9.51% | −21.06% | +39.59% | 39 | |||
| MNKD | Mannkind Corporation | $981M | −0.98% | −15.17% | −46.74% | −40.78% | 31 | |||
| MRVI | Maravai LifeSciences Holdings, Inc. | $973M | +0.31% | −4.80% | +101.54% | +98.48% | 40 | ✓ | ||
| AKTS | Aktis Oncology, Inc. | $926M | −0.90% | −26.42% | — | — | 23 | — | ||
| MLTX | MoonLake Immunotherapeutics | $886M | −2.59% | −16.89% | −23.07% | −4.88% | 24 | |||
| RIGL | Rigel Pharmaceuticals Inc. (New) | $881M | −0.68% | +5.55% | +9.32% | +74.51% | 48 | ✓ | ✓ | |
| KURA | Kura Oncology, Inc. | $874M | −2.24% | −14.96% | −7.51% | −3.22% | 28 | |||
| ANRO | Alto Neuroscience Inc. | $867M | −1.72% | −28.23% | +21.97% | +269.22% | 22 | |||
| SPTX | Seaport Therapeutics, Inc. | $861M | +3.73% | −27.35% | — | — | 35 | — | ||
| CYRX | CryoPort, Inc. | $859M | −1.83% | +2.02% | +73.33% | +77.02% | 46 | ✓ | ✓ | |
| JBIO | Jade Biosciences, Inc. | $853M | +0.15% | −22.67% | −12.90% | +47.85% | 29 | |||
| ALMS | Alumis Inc. | $849M | −7.62% | −27.86% | −37.91% | +31.45% | 22 | |||
| ABUS | Arbutus Biopharma Corporation | $814M | +1.95% | −17.19% | −12.89% | −2.10% | 32 | |||
| ARDX | Ardelyx, Inc. | $806M | +2.24% | −6.18% | −45.28% | −36.33% | 32 | Low | ||
| AVBP | ArriVent BioPharma, Inc. | $793M | +0.68% | −42.08% | −19.48% | −22.49% | 23 | |||
| CRVS | Corvus Pharmaceuticals, Inc. | $792M | −0.32% | −27.57% | +21.82% | +31.93% | 24 | |||
| GERN | Geron Corp | $771M | −0.83% | −9.16% | −9.85% | −6.30% | 34 | |||
| HELP | Helus Pharma Inc. | $767M | −1.14% | −20.88% | — | — | 39 | — | ||
| ANL | Adlai Nortye Group Ltd. | $757M | −7.44% | −27.47% | +666.20% | +580.98% | 30 | ✓ | ||
| APMD | Apnimed, Inc. | $742M | −3.37% | −32.59% | — | — | 32 | — | ||
| OBX | Obsidian Therapeutics, Inc. | $741M | +1.92% | −28.12% | — | — | 33 | — | ||
| ANNX | Annexon, Inc. | $726M | −4.18% | −6.38% | −26.89% | +22.13% | 33 | |||
| IMMX | Immix Biopharma, Inc. | $720M | −2.07% | −29.90% | +62.72% | +240.40% | 28 | |||
| LXRX | Lexicon Pharmaceuticals, Inc. | $716M | −0.62% | −20.40% | +39.13% | +11.11% | 26 | |||
| GYRE | Gyre Therapeutics, Inc. | $711M | −3.58% | −3.29% | −8.36% | −22.88% | 39 | |||
| COLL | Collegium Pharmaceutical, Inc. | $701M | +4.55% | +3.07% | −51.38% | −29.74% | 44 | |||
| IVA | Inventiva S.A. | $678M | 0.00% | −25.65% | −38.28% | −37.74% | 27 | Low | ||
| VSTM | Verastem, Inc. | $675M | +3.49% | +5.04% | −0.13% | −17.01% | 49 | ✓ | ✓ | |
| PHAR | Pharming Group N.V. | $668M | +2.12% | −8.63% | −45.44% | −34.02% | 38 | |||
| AVTX | Avalo Therapeutics, Inc. | $644M | −1.42% | −26.32% | −34.80% | −13.39% | 22 | Low | ||
| WVE | Wave Life Sciences Ltd. | $619M | −1.59% | −30.72% | −81.82% | −60.33% | 20 | Low | ||
| ZVRA | Zevra Therapeutics, Inc. | $617M | −1.54% | −12.19% | +14.17% | −4.30% | 38 | |||
| OLMA | Olema Pharmaceuticals, Inc. | $614M | −3.13% | −30.47% | −72.80% | −36.74% | 17 | Low | ||
| DSGN | Design Therapeutics, Inc. | $612M | −0.51% | −20.41% | +3.73% | +49.92% | 23 | |||
| IRWD | Ironwood Pharmaceuticals, Inc. | $593M | +0.28% | −11.33% | +6.82% | +143.24% | 36 | |||
| NVCT | Nuvectis Pharma, Inc. | $592M | −0.83% | −17.88% | +138.41% | +190.79% | 36 | ✓ | ||
| CLYM | Climb Bio, Inc. | $592M | −0.19% | −26.02% | +157.25% | +414.50% | 29 | ✓ | ||
| AQST | Aquestive Therapeutics, Inc. | $586M | −1.28% | −4.16% | −28.64% | −30.78% | 46 | ✓ | ||
| CRMD | CorMedix Inc. | $576M | 0.00% | −4.77% | −36.46% | −30.15% | 41 | |||
| PHAT | Phathom Pharmaceuticals, Inc. | $566M | +5.71% | −9.31% | −55.39% | −40.94% | 47 | |||
| SGMT | Sagimet Biosciences Inc. Series A | $566M | −5.45% | −27.87% | +27.45% | −0.72% | 29 | ✓ | ||
| FTH | Faeth Therapeutics, Inc. | $556M | −7.02% | −43.45% | — | — | 25 | — | ||
| SLN | Silence Therapeutics Plc | $551M | +1.24% | −27.93% | +47.70% | +63.27% | 24 | ✓ | ||
| STTK | Shattuck Labs, Inc. | $551M | −2.91% | −10.72% | +46.03% | +189.67% | 34 | |||
| PBYI | Puma Biotechnology Inc | $522M | +0.79% | +10.27% | +71.43% | +92.82% | 61 | ✓ | ✓ | |
| ACRS | Aclaris Therapeutics, Inc. | $511M | −2.59% | −38.82% | +12.29% | +76.96% | 27 | |||
| DRUG | Bright Minds Biosciences Inc. | $507M | −1.27% | −15.79% | −35.02% | −21.95% | 36 | |||
| CTMX | CytomX Therapeutics, Inc. | $507M | −4.09% | −17.10% | −47.65% | −34.41% | 27 | Low | ||
| EOLS | Evolus, Inc. | $496M | −3.86% | −8.72% | +8.57% | +20.33% | 38 | ✓ | ||
| MNPR | Monopar Therapeutics Inc. | $484M | +1.42% | −29.93% | +11.94% | −28.37% | 26 | |||
| CBIO | Crescent Biopharma, Inc. | $480M | −2.56% | −33.09% | +6.07% | +22.73% | 33 | |||
| EVO | Evotec SE | $478M | +5.95% | −12.58% | −53.73% | −63.92% | 35 | |||
| ALT | Altimmune, Inc. | $473M | −4.94% | −28.48% | −36.01% | −42.25% | 20 | Low | ||
| OCS | Oculis Holding AG | $469M | −5.91% | −28.80% | −64.10% | −65.86% | 19 | Low | ||
| ARVN | Arvinas, Inc | $447M | −0.29% | −17.43% | −42.50% | −30.41% | 29 | Low | ||
| RZLT | Rezolute, Inc. | $446M | −8.24% | +1.93% | +79.24% | −47.58% | 47 | ✓ | ||
| KMDA | Kamada Ltd | $444M | −1.17% | −6.06% | +7.65% | +10.47% | 38 | |||
| EPRX | Eupraxia Pharmaceuticals Inc. | $441M | −1.35% | −18.74% | −12.72% | +8.93% | 36 | |||
| MPLT | MapLight Therapeutics, Inc. | $438M | −0.83% | −35.35% | −55.54% | — | 21 | Low | ||
| NGNE | Neurogene, Inc. | $431M | +2.88% | −34.16% | +7.67% | −29.85% | 26 | |||
| PRTA | Prothena Corporation plc | $429M | +0.12% | +0.48% | −12.36% | −19.13% | 46 | |||
| OVID | Ovid Therapeutics Inc. | $428M | 0.00% | −19.19% | +34.36% | +38.61% | 33 | |||
| DMAC | DiaMedica Therapeutics Inc. | $422M | −2.05% | +17.30% | −3.77% | +8.50% | 50 | ✓ | ✓ | |
| PRE | Prenetics Global Limited | $415M | −3.15% | −10.75% | +30.79% | +49.17% | 41 | ✓ | ||
| ASMB | Assembly Biosciences, Inc | $414M | +0.93% | −21.37% | −39.64% | −25.78% | 27 | Low | ||
| SPRY | ARS Pharmaceuticals, Inc. | $403M | −2.96% | −7.53% | −66.27% | −64.04% | 35 | Low | ||
| CAPR | Capricor Therapeutics Inc | $400M | −4.22% | −23.01% | −77.17% | −1.93% | 34 | |||
| AVIR | Atea Pharmaceuticals, Inc. | $399M | −7.03% | −11.47% | +29.69% | +48.87% | 31 | |||
| GALT | Galectin Therapeutics Inc. | $372M | −1.36% | −2.41% | −12.50% | −28.63% | 44 | ✓ | ||
| RLMD | Relmada Therapeutics, Inc. | $358M | −3.57% | −27.03% | −32.92% | +60.40% | 32 | |||
| EBS | Emergent Biosolutions, Inc. | $354M | 0.00% | +8.65% | −44.09% | −25.70% | 55 | ✓ | ||
| IRD | Opus Genetics, Inc. | $353M | −3.30% | −29.55% | +103.98% | +105.00% | 38 | ✓ | ||
| ARCT | Arcturus Therapeutics Holdings Inc. | $342M | −7.56% | −29.80% | +81.40% | −42.65% | 39 | ✓ | ||
| ENTA | Enanta Pharmaceuticals, Inc | $336M | −2.95% | −9.03% | −29.11% | −2.70% | 35 | |||
| TTRX | Turn Therapeutics Inc. | $322M | +4.81% | −17.46% | +181.98% | +70.66% | 44 | ✓ | ||
| INDP | Indaptus Therapeutics, Inc. | $318M | −7.53% | −39.29% | −24.05% | −45.16% | 45 | ✓ | ||
| CTNM | Contineum Therapeutics, Inc. | $317M | −3.33% | −41.10% | −28.78% | −31.77% | 24 | Low | ||
| CYPH | Cypherpunk Technologies Inc. | $306M | −7.75% | +18.02% | +125.86% | — | 46 | ✓ | ✓ | |
| BNTC | Benitec Biopharma Inc. | $301M | −3.94% | −24.98% | −38.46% | −44.73% | 28 | Low |
How the industry explorer works
Industries. Each company is placed by the Standard Industrial Classification (SIC) code it reports in its SEC filings, then grouped into one of 11 sectors. SIC has three levels below the sector: major groups (two digits, e.g. 28 Chemicals), industry groups (three digits, e.g. 283 Drugs) and industries (four digits, e.g. 2834 Pharmaceutical Preparations). Codes ending in 0 or 00 mean a company is classified at the group level only; those appear as "(general)". Groups with a single sub-group are merged so every drill step shows a choice.
Cap-weighted vs median. The cap-weighted return is how the group performed as a basket, so the largest companies dominate it. The median stock shows what a typical member did. A wide gap between the two means a few giants are carrying, or dragging, the group.
Companies, not tickers. A company with several share classes (Alphabet, Berkshire) counts once, through its most traded class. Blank-check companies (SPACs) are left out. Use the size filter to drop micro-caps, which dominate the counts in industries like biotech.
Find a company. Search by ticker or name to jump to the industry a company is classified in. It stays marked on the map and its path stays above the figures while you move between levels, so you can see which sector, group and industry it belongs to and how it ranks there. Funds and ETFs have no industry and are not on the map.
Figures are price returns (excluding dividends) as of the latest close, refreshed each trading day after the market closes. The S&P 500 comparison uses SPY over the same period.